Cost-Utility Analysis of Injectable Paliperidone Palmitate 3-Month Formulation Versus Injectable Risperidone and Oral Antipsychotics For The Treatment Of Schizophrenia In Colombia
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.1263
https://www.valueinhealthjournal.com/article/S1098-3015(18)31566-3/fulltext
Section Title :
Section Order :
521
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31566-3&doi=10.1016/j.jval.2018.04.1263